PPT-Long Acting Injectable Agents for HIV Prevention

Author : giovanna-bartolotta | Published Date : 2017-12-17

Nyaradzo M Mgodi MBChB MMed On behalf of the HPTN076 Team UZUCSF Annual Research Day May 05 2017 Harare Background Introduction to Rilpivirine TMC 278 HPTN076

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Long Acting Injectable Agents for HIV Pr..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Long Acting Injectable Agents for HIV Prevention: Transcript


Nyaradzo M Mgodi MBChB MMed On behalf of the HPTN076 Team UZUCSF Annual Research Day May 05 2017 Harare Background Introduction to Rilpivirine TMC 278 HPTN076 Study Design. Despite this signi64257cant progress the number of children becoming newly infected with HIV remains unacceptably high About 240 000 210 000280 000 children became infected with HIV in 2013 The risk of a mother living with HIV passing the virus to h What is DMPA? . Explain what injectable contraceptives are.. Explain what kind of injectable contraceptive DMPA is.. Describe how . DMPA works.. List the different names of DMPA.. Explain why women might like or not like DMPA.. A Winnable Battle. Centers for Disease Control and Prevention. Burden of HIV in the United States. . . 1.2 M . ~. 50K. 1.2 million people . living with HIV. Approximately . 50,000 new infections annually. By Charles . Olusegun. DOHERTY. Background. The . Project was . premised on the fact that many . programmes. and activities on HIV and AIDS have never been taking into cognizance the inclusion of persons with Disabilities (PWD) in . Centers for Disease Control and Prevention. Burden of HIV in the United States. . . 1.2 M . ~. 50K. 1.2 million people . living with HIV. Approximately . 50,000 new infections annually. . Learning Objectives. EARLY VS DEFERRED ART. The Case is Made. Should Early-Stage Asymptomatic HIV Patients Receive ART? . The INSIGHT START Study. The CD4 Cell Count As a Measure . of Immune Deficiency in HIV Patients. PrEP. Anton Pozniak . MD FRCP. Consultant Physician . . Disclosures. I have received honoraria, travel sponsorship and research grants from:. Gilead Sciences . Janssen. MSD. ViiV Healthcare. BUT… success depends on adherence.. Stanislavski’s “Method” was indeed a revolution in acting focusing on an actor’s inner motivation.. Instructors who came after Stanislavski or disagreed with his methods also gained . prominence:. T. oolbox?. Objectives for Module 1. Our . Mission(s) . Today:. Discuss the difference between HIV prevention for HIV-negative people, HIV prevention for people living with HIV, and HIV testing. Discuss . Sinead Delany-Moretlwe. Wits RHI, University of the Witwatersrand, Johannesburg. Conflict of Interest. I have received drug donation awarded to my institution from Gilead Sciences.. New option for prevention. HIV1 and slower to progress to AIDS.. Most cases are due to type1.. Modes of transmission. 1-sexual.. 2- perinatal.. 3-parenteral(occupational and intravenous drug injection).. 4- blood transfusion.. Injection. s. Percutaneous . introduction of a medicinal substance, fluid or nutrient into the body. (e. g. intradermal, subcutaneous, intramuscular, . intravenous). Syringe . Needle . Unsafe Use of Injections . Teaching for Anticipated Emergencies. (Auto-injectable epinephrine & glucagon). June, 2018. Learning Objectives. As a result of this training, participants will:. Be able to recognize potential side effects of auto-injectable epinephrine and glucagon and what to do if side effects occur. Presented by Carol Nati MD, MS, DFAPA. Medical Director, MHMR of Tarrant County. Overview. Long Acting Injectable Antipsychotic Medications are underutilized in Texas.. They have been proven to work well..

Download Document

Here is the link to download the presentation.
"Long Acting Injectable Agents for HIV Prevention"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents